Kate Ingarfield

Papers

Total Citations

H-Index

About

Dr. Kate Ingarfield is a leading surgical oncologist whose research focuses on optimizing treatment outcomes for oropharyngeal carcinoma, particularly in the context of human papillomavirus (HPV)-associated disease. Her most cited work, "Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma" (2024, 16 citations), provides critical comparative evidence on two advanced surgical approaches: transoral robotic surgery (TORS) and transoral laser microsurgery (TLM). This study demonstrates that while both techniques achieve excellent oncological results for HPV-positive oropharyngeal squamous cell carcinoma, TORS may offer superior margin clearance around tumors—a finding with direct implications for surgical planning and recurrence prevention. By systematically evaluating these minimally invasive modalities, Dr. Ingarfield has helped clarify their relative benefits, enabling more personalized surgical decision-making. Her work bridges the gap between technological innovation and clinical practice, offering surgeons and patients clearer guidance on treatment selection. With growing interest in de-escalation strategies for HPV-related cancers, her contributions are increasingly influential, shaping how clinicians balance functional preservation with oncologic safety in a rapidly evolving field.